161 related articles for article (PubMed ID: 7509142)
21. Susceptibility of human immunodeficiency virus type 1 replication in vitro to acyclic adenosine analogs and synergy of the analogs with 3'-azido-3'-deoxythymidine.
Smith MS; Brian EL; De Clercq E; Pagano JS
Antimicrob Agents Chemother; 1989 Sep; 33(9):1482-6. PubMed ID: 2479334
[TBL] [Abstract][Full Text] [Related]
22. Synergistic inhibition of human immunodeficiency virus type 1 replication in vitro by two-drug and three-drug combinations of 3'-azido-3'-deoxythymidine, phosphonoformate, and 2',3'-dideoxythymidine.
Kong XB; Zhu QY; Ruprecht RM; Watanabe KA; Zeidler JM; Gold JW; Polsky B; Armstrong D; Chou TC
Antimicrob Agents Chemother; 1991 Oct; 35(10):2003-11. PubMed ID: 1722077
[TBL] [Abstract][Full Text] [Related]
23. Duplicated sequence motif in the long terminal repeat of maedi-visna virus extends cell tropism and is associated with neurovirulence.
Oskarsson T; Hreggvidsdóttir HS; Agnarsdóttir G; Matthíasdóttir S; Ogmundsdóttir MH; Jónsson SR; Georgsson G; Ingvarsson S; Andrésson OS; Andrésdóttir V
J Virol; 2007 Apr; 81(8):4052-7. PubMed ID: 17287273
[TBL] [Abstract][Full Text] [Related]
24. [Anti-retroviral activity and molecular-biochemical action mechanism of 2',3'-dideoxynucleoside analogs and 9-(2-phosphonylmethoxyethyl) purine derivatives].
Balzarini J
Verh K Acad Geneeskd Belg; 1991; 53(1):61-98. PubMed ID: 1647085
[TBL] [Abstract][Full Text] [Related]
25. Ribavirin antagonizes inhibitory effects of pyrimidine 2',3'-dideoxynucleosides but enhances inhibitory effects of purine 2',3'-dideoxynucleosides on replication of human immunodeficiency virus in vitro.
Baba M; Pauwels R; Balzarini J; Herdewijn P; De Clercq E; Desmyter J
Antimicrob Agents Chemother; 1987 Oct; 31(10):1613-7. PubMed ID: 3435108
[TBL] [Abstract][Full Text] [Related]
26. HIV inhibitors targeted at the reverse transcriptase.
De Clercq E
AIDS Res Hum Retroviruses; 1992 Feb; 8(2):119-34. PubMed ID: 1371690
[TBL] [Abstract][Full Text] [Related]
27. Deaza- and deoxyadenosine derivatives: synthesis and inhibition of animal viruses as human infection models.
Vittori S; Salvatori D; Volpini R; Vincenzetti S; Vita A; Taffi S; Costanzi S; Lambertucci C; Cristalli G
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):877-81. PubMed ID: 14565301
[TBL] [Abstract][Full Text] [Related]
28. Hydroxyurea potentiates the antiherpesvirus activities of purine and pyrimidine nucleoside and nucleoside phosphonate analogs.
Neyts J; De Clercq E
Antimicrob Agents Chemother; 1999 Dec; 43(12):2885-92. PubMed ID: 10582877
[TBL] [Abstract][Full Text] [Related]
29. Resistance of visna virus to interferon.
Carroll D; Ventura P; Haase A; Rinaldo CR; Overall JC; Glasgow LA
J Infect Dis; 1978 Nov; 138(5):614-7. PubMed ID: 213502
[TBL] [Abstract][Full Text] [Related]
30. Inhibitory effect of 2',3'-didehydro-2',3'-dideoxynucleosides on infectivity, cytopathic effects, and replication of human immunodeficiency virus.
Hamamoto Y; Nakashima H; Matsui T; Matsuda A; Ueda T; Yamamoto N
Antimicrob Agents Chemother; 1987 Jun; 31(6):907-10. PubMed ID: 3039911
[TBL] [Abstract][Full Text] [Related]
31. Activity of acyclic nucleoside phosphonate analogues against human immunodeficiency virus in monocyte/macrophages and peripheral blood lymphocytes.
Balzarini J; Perno CF; Schols D; De Clercq E
Biochem Biophys Res Commun; 1991 Jul; 178(1):329-35. PubMed ID: 2069572
[TBL] [Abstract][Full Text] [Related]
32. Long-term Visna virus infection of sheep choroid plexus cells: initiation and preliminary characterization of the carrier cultures.
Trowbridge RS
Infect Immun; 1975 Apr; 11(4):862-8. PubMed ID: 47311
[TBL] [Abstract][Full Text] [Related]
33. Divergent anti-human immunodeficiency virus activity and anabolic phosphorylation of 2',3'-dideoxynucleoside analogs in resting and activated human cells.
Gao WY; Agbaria R; Driscoll JS; Mitsuya H
J Biol Chem; 1994 Apr; 269(17):12633-8. PubMed ID: 8175673
[TBL] [Abstract][Full Text] [Related]
34. Isolation of visna-maedi virus from the choroid plexus of an apparently healthy sheep in Italy.
Caporale VP; Lelli R; Rutili D
Vet Res Commun; 1985 Apr; 9(2):115-22. PubMed ID: 2988186
[TBL] [Abstract][Full Text] [Related]
35. Lack of synergy in the inhibition of HIV-1 reverse transcriptase by combinations of the 5'-triphosphates of various anti-HIV nucleoside analogs.
White EL; Parker WB; Ross LJ; Shannon WM
Antiviral Res; 1993 Dec; 22(4):295-308. PubMed ID: 7506513
[TBL] [Abstract][Full Text] [Related]
36. Targeted therapy of human immunodeficiency virus-related disease.
Mitsuya H; Yarchoan R; Kageyama S; Broder S
FASEB J; 1991 Jul; 5(10):2369-81. PubMed ID: 1712326
[TBL] [Abstract][Full Text] [Related]
37. Antiviral effects of 3'-azido-3'-deoxythymidine, 2',3'-dideoxycytidine, and 2',3'-dideoxyadenosine against simian acquired immunodeficiency syndrome-associated type D retrovirus in vitro.
Tsai CC; Follis KE; Benveniste RE
AIDS Res Hum Retroviruses; 1988 Oct; 4(5):359-68. PubMed ID: 2461724
[TBL] [Abstract][Full Text] [Related]
38. Comparison of in vitro biological properties and mouse toxicities of three thymidine analogs active against human immunodeficiency virus.
Mansuri MM; Hitchcock MJ; Buroker RA; Bregman CL; Ghazzouli I; Desiderio JV; Starrett JE; Sterzycki RZ; Martin JC
Antimicrob Agents Chemother; 1990 Apr; 34(4):637-41. PubMed ID: 1693057
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and anti-HIV activity of [ddN]-[ddN] dimers and benzimidazole nucleoside dimers.
Li GR; Liu J; Pan Q; Song ZB; Luo FL; Wang SR; Zhang XL; Zhou X
Chem Biodivers; 2009 Dec; 6(12):2200-8. PubMed ID: 20020452
[TBL] [Abstract][Full Text] [Related]
40. Anti-retrovirus activity of 3'-fluoro- and 3'-azido-substituted pyrimidine 2',3'-dideoxynucleoside analogues.
Balzarini J; Baba M; Pauwels R; Herdewijn P; De Clerq E
Biochem Pharmacol; 1988 Jul; 37(14):2847-56. PubMed ID: 2840080
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
